These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25083986)

  • 1. The microbial basis of inflammatory bowel diseases.
    Dalal SR; Chang EB
    J Clin Invest; 2014 Oct; 124(10):4190-6. PubMed ID: 25083986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IBD and the gut microbiota--from bench to personalized medicine.
    Bellaguarda E; Chang EB
    Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota and inflammatory bowel diseases.
    Miyoshi J; Chang EB
    Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food and the gut microbiota in inflammatory bowel diseases: a critical connection.
    Albenberg LG; Lewis JD; Wu GD
    Curr Opin Gastroenterol; 2012 Jul; 28(4):314-20. PubMed ID: 22573192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota and IBD].
    Seksik P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease.
    Andoh A; Benno Y; Kanauchi O; Fujiyama Y
    Curr Pharm Des; 2009; 15(18):2066-73. PubMed ID: 19519444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
    Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
    United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism.
    Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S6-9. PubMed ID: 20535026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers.
    Said HS; Suda W; Nakagome S; Chinen H; Oshima K; Kim S; Kimura R; Iraha A; Ishida H; Fujita J; Mano S; Morita H; Dohi T; Oota H; Hattori M
    DNA Res; 2014 Feb; 21(1):15-25. PubMed ID: 24013298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of intestinal bacteria in human inflammatory bowel disease.
    Vanderploeg R; Panaccione R; Ghosh S; Rioux K
    Infect Dis Clin North Am; 2010 Dec; 24(4):977-93, ix. PubMed ID: 20937461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease.
    Qi Y; Zang SQ; Wei J; Yu HC; Yang Z; Wu HM; Kang Y; Tao H; Yang MF; Jin L; Zen K; Wang FY
    Genomics; 2021 Jan; 113(1 Pt 2):664-676. PubMed ID: 33010388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota in inflammatory bowel disease: friend of foe?
    Fava F; Danese S
    World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.